This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Logistic and Cox regression models identified riskfactors for in-hospital and long-term mortality.ResultsAmong the 212 patients, 79.72% (169/212) had HCM, 16.98% (36/212) had RCM, and 3.30% (7/212) had RP-HCM. BackgroundPediatric cardiomyopathies are rare but life-threatening conditions with high mortality.
ObjectiveTo explore the riskfactors for cardiotoxicity in patients with gastrointestinal (GI) tumors treated with fluorouracil drugs.MethodsThis study included patients with GI tumors who received fluorouracil at our hospital between January 2018 and April 2022. The demographic and clinical characteristics were collected.
Background and AimHypertension (HTN) is a widespread global health challenge, and its increasing prevalence is attributed to individual and environmental riskfactors. Exposure to total PCBs correlated with an elevated risk of hypertension (OR=1.78, 95% CI: 1.302.44).
BackgroundLeft ventricular hypertrophy (LVH) is often a complication of hypertension and an independent riskfactor for cardiovascular events. In Ethiopia, there is a scarcity of data on the prevalence and associated factors of left ventricular hypertrophy among hypertensive adults. p-values of <0.05
Hypertension, Ahead of Print. Hypertension is a leading riskfactor for cardiovascular morbidity and mortality. Individual patient responses vary, and further research is needed to identify those who may benefit most.
Officially published by the AHA six months ago, CKM syndrome defines the connections and risks associated with obesity, type 2 diabetes, chronic kidney disease, and cardiovascular disease. The researchers analyzed 2011-2020 NHANES survey results and laboratory measurements from 10,762 nationally representative US adults (47.3yr avg.
The Minneapolis Heart Institute Foundation (MHIF) is presenting leading research focused on trends in ST-elevation myocardial infarction (STEMI), the most severe form of a heart attack, at the American College of Cardiology’s Annual Scientific Session (ACC.24), 24), being held April 6-8 in Atltanta, GA.
Background and aims Hypertension is a leading riskfactor for cardiovascular disease. EHRs can be used for epidemiological research. This study aimed to identify codelists used to define hypertension in studies that use EHRs and generate recommended codelists to support reproducibility and consistency.
A projected rise in heart disease and stroke – along with several key riskfactors, including high blood pressure and obesity – is likely to triple related costs to $1.8 Smith Center for Outcomes Research in Cardiology and director of the cardiac critical care unit at Beth Israel Deaconess Medical Center in Boston, Mass.
Hypertension is a leading cause of morbidity and mortality worldwide and poses a major riskfactor for cardiovascular diseases and chronic kidney disease.
Background and objectives Hypertension is one of the most serious riskfactors and the leading cause of mortality in patients with cardiovascular diseases (CVDs). It is necessary to accurately predict the mortality of patients suffering from CVDs with hypertension. Methods The synopsis of our research is as follows.
There was an increase in hypertensive disorders of pregnancy and most associated riskfactors between 2010 and 2021 overall in the entire U.S. pregnant population, according to a research letter published online June 10 in the Journal of the American Medical Association.
Albuminuriaincreased urine albumin excretionis associated with cardiovascular mortality among patients with diabetes, hypertension, chronic kidney disease, or heart failure, as well as among adults with few cardiovascular riskfactors.
Hypertension, Ahead of Print. Elevated blood pressure is a well-established riskfactor for age-related cognitive decline. Long linked to cognitive impairment on vascular bases, increasing evidence suggests a potential association of hypertension with the neurodegenerative pathology underlying Alzheimer disease.
Hypertension, Ahead of Print. Hypertension is the primary modifiable riskfactor for cardiovascular, renal, and cerebrovascular diseases and is considered the main contributing factor to morbidity and mortality worldwide.
The Lasso regression was used to preliminarily screen potential riskfactors, which were entered into the multivariable logistic regression analysis to identify preoperative independent riskfactors for postoperative AKI. Results220 patients (36.2%) developed AKI after surgery.
Hypertension, Ahead of Print. Previous basic and clinical investigations have identified various pathogenic factors and determinants of risk that contribute to hypertension. Nevertheless, the pathogenesis of hypertension has not been fully elucidated.
BackgroundThe association between healthy lifestyle and American Heart Association (AHA) Life's Essential 8 (LE8) score and apparent treatment-resistant hypertension(aTRH)remains uncertain. to 0.20) for uncontrolled hypertension with 12 and 34 antihypertensive drugs, respectively. to 0.76) and 0.07 (95% CI, 0.02
BackgroundAsian people in the United States have different sociodemographic and health‐related characteristics that might affect cardiovascular disease (CVD) risk by ethnicity and birthplace. However, they are often studied as a monolithic group in health care research.
Driven by common pathophysiologic underpinnings (eg, inflammation and neurohormonal dysregulation), cardiovascular disease, cognitive impairment, and frailty also share the following riskfactors: hypertension, diabetes, obesity, sedentary behavior, and tobacco use.
IntroductionPatients with cognitive impairment often have a history of cardiovascular disease (CVD) or multiple cardiovascular riskfactors (CRFs) such as hypertension, obesity, and hypercholesterolemia. The literature reports that CVD with CRFs may increase the risk of developing vascular dementia and Alzheimer’s Disease.
ICAS is the leading cause of stroke globally, with high recurrence risk, especially in Asian, Black, and Hispanic populations. Various riskfactors, including hypertension, diabetes, hyperlipidemia, smoking, and advanced age lead to ICAS, which in turn results in stroke through different mechanisms.
Obesity, a major riskfactor for cardiovascular disease (CVD), is associated with hypertension and vascular dysfunction. Perivascular adipose tissue (PVAT), a metabolically active tissue surrounding blood vess.
Metabolic syndrome is characterized as the co-occurrence of interrelated cardiovascular riskfactors, including insulin resistance, hyperinsulinemia, abdominal obesity, dyslipidemia and hypertension. Once week.
Hypertension, Ahead of Print. Cerebral small vessel disease is common in older adults and increases the risk of stroke, cognitive impairment, and dementia. While often attributed to midlife vascular riskfactors such as hypertension, factors from earlier in life may contribute to later small vessel disease risk.
Factors such as aging populations, rising rates of obesity, hypertension, and other cardiovascular conditions contribute to this increase. Here are a few key considerations: Early Detection and Diagnosis: Early diagnosis of AFib is critical in reducing the risk of stroke and other complications.
The latest research on socioeconomic status (SES) and stroke continues to demonstrate that individuals with low SES are at a higher risk of stroke, receive lower-quality care, and experience poorer outcomes. Stroke, Ahead of Print. Addressing stroke inequalities requires an interdisciplinary approach.
Factors such as aging populations, rising rates of obesity, hypertension, and other cardiovascular conditions contribute to this increase. Here are a few key considerations: Early Detection and Diagnosis: Early diagnosis of AFib is critical in reducing the risk of stroke and other complications.
Introduction Hypertension is the leading modifiable riskfactor for cardiovascular disease and is implicated in half of all strokes and myocardial infarctions. One-third of the adults in Scotland have hypertension yet only a quarter of them have their blood pressure (BP) controlled to target (<140/90 mm Hg).
Five highly-anticipated late-breaking clinical trial sessions, an ACC/AHA guidelines update session and a host of featured clinical research sessions have been announced by program planners for the American College of Cardiology’s 73 rd Annual Scientific Session & Expo to be held April 6-8 in Atlanta, GA.
Hypertension, diabetes, hyperlipidemia, and chronic kidney disease are well-known cardiovascular riskfactors for ICH. However, the relationship between the polygenic profiles (PP) of these riskfactors and ICH risk in AF patients on anticoagulation remains unclear.
A Kaplan-Meier curve validated these findings, showing a higher AIS risk with vertebral versus carotid artery dissections (Figure). This highlights the need for research into tailored management strategies for these patients to reduce stroke risk.
The prevalence of HF riskfactors was high: hypertension, 61.9%; former or current smoking, 53.7%; obesity 34.8%; diabetes; 24.7%; and chronic kidney disease; 22%. Results:Median age was 73 (25th–75th percentile 67–81) years, 53.2% were female, 25.6% were Black, 12.8% were Chinese, and 40.0% were White. were female, 25.6%
” — Dr. Matthew Walker This statement may seem a bit hyperbolic, but it accurately summarizes most of the available research on sleep and health. Sleep duration has traditionally received most of the attention as a modifiable riskfactor. . “The shorter your sleep, the shorter your life.”
This study investigates the associations between EPVS and a spectrum of clinical factors and conditions in a large community-based sample in the northeastern United States.Method:This research was conducted on a subset of the Geisinger DiscovEHR Initiative Cohort. and hypertension (OR, 3.1;
Background:Patent foramen ovale (PFO) is an independent riskfactor for neurovascular injury such as stroke. We previously found that large PFO shunt is associated with increased long-term risk of vascular dementia. However, the mechanism underlying this association remains poorly understood.
A, Normal axillary lymph nodes measuring milla1cf Fri, 05/10/2024 - 08:12 May 10, 2024 — According to the Summa Cum Laude Award-Winning Online Poster presented during the 124th ARRS Annual Meeting , fat-enlarged axillary nodes on screening mammograms can predict high cardiovascular disease (CVD) risk, Type 2 diabetes (T2DM), and hypertension (HTN).
Purpose Construction of a prediction model to predict the risk of major adverse cardiovascular events (MACE) in the long term after percutaneous coronary intervention (PCI) in patients with acute ST-segment elevation myocardial infarction (STEMI).
Research has increasingly shown that quality sleep plays a pivotal role in heart health. Sleep deprivation or poor sleep can lead to an increased risk of developing conditions such as hypertension, heart disease, stroke, and irregular heart rhythms (arrhythmias).
However, prolonged exposure to stress can lead to persistently high levels of these hormones, contributing to increased heart rate, elevated blood pressure, and inflammation, all of which raise the risk of heart disease. Research has shown that individuals with depression are more likely to develop heart disease.
Food and Drug Administration (FDA) in 2021 as a once-weekly injection for chronic weight management in adults with obesity and at least one weight-related condition such as type 2 diabetes or hypertension. Previous research has demonstrated that adults with obesity who were given once-weekly survodutide 4.8 mg lost up to 18.7%
Background There are limited data on structural heart disease among people living with HIV in southern Africa, where the success of antiretroviral therapy (ART) has drastically improved life expectancy and where riskfactors for cardiovascular disease are prevalent.
We also plan several live virtual webinars each year and present original research during poster sessions at meetings like that of the National Lipid Association. ” Learners can see some of the CMHC experts in person on Aug. Visit cardiometabolichealth.org to learn more.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
52 
Let's personalize your content